Lunai Bioworks Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Lunai Bioworks Inc. (LNAI) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$2.05 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-09-29
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2016-09-30 was $214.16K.
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2015-03-31 was $0.00.
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2013-12-31 was $255.53K.
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2013-09-30 was $0.00.
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was -$2.05M.
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $0.00.
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Lunai Bioworks Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $34.00.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | -$2.05M 10-K · filed 2025-09-29 | ||||
| 2024-06-30 | $0.00 10-K · filed 2025-09-29 | ||||
| 2023-06-30 | $0.00 10-K/A · filed 2025-02-19 | ||||
| 2022-06-30 | $34.00 10-K · filed 2023-10-02 | ||||
| 2018-06-30 | $218.06K 10-K · filed 2019-09-30 | ||||
| 2017-06-30 | $244.72K 10-K · filed 2018-10-01 | ||||
| 2017-03-31 | $215.97K 10-Q · filed 2017-05-15 | ||||
| 2016-12-31 | $215.97K 10-Q · filed 2017-02-14 | ||||
| 2016-09-30 | $214.16K 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $32.21K 10-K · filed 2017-11-20 | ||||
| 2015-12-31 | $2.46K 10-Q · filed 2017-02-14 | ||||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-13 | $8.39K 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | $8.39K 10-Q · filed 2016-02-12 | -$3.06K 10-K · filed 2016-09-28 | $8.39K 10-K · filed 2015-03-31 | ||
| 2013-12-31 | $255.53K derived: 10-KT 12 month − 10-Q 9 month · filed 2015-09-28 | $255.53K derived: sum of 2 quarters · filed 2015-09-28 | $255.53K derived: sum of 3 quarters · filed 2015-09-28 | $283.38K 10-KT · filed 2015-09-28 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $27.85K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $27.85K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $27.85K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |